I propose to take Questions Nos. 7 and 21 together.
I assure the Deputies that the Government is committed to the continued development of our general practice service and improving access to GP services for all patients around the country. Over €340 million in additional annual investment in general practice has been provided under the 2019 and 2023 GP GMS agreements. Those agreements provide for increased GP capitation fees, increased and new supports for practices and new fees for additional services. By any measure, that is a considerable support provided by the State and by the taxpayer to private practices. It is important to remember that. The positive impact of this investment is seen in the increased number of doctors both applying for and undertaking GP training. Annual intake into the GP training scheme increased by 80% from 2019 to 2024. We have further increased the number of new entrant training places this year by 50 to 400. In addition, recruitment of GPs from abroad continues under the international medical graduate rural GP programme, which targets the placement of GPs to rural and under-served areas.
A strategic review of general practice that is examining the range of issues affecting it is under way and will be completed this year. The review will examine issues related to capacity and will consider further possible mechanisms to attract GPs to rural and under-served areas. The review will set out recommended actions for more sustainable general practice delivery for the whole community. While the existing GMS GP contract has been significantly updated, including via a circular, a new approach must also be developed. The strategic review will identify the arrangements necessary to improve our current system of GP care and that will determine any changes required in a new contract.
There is hugely significant investment in GPs, particularly in chronic disease management, which has been of real benefit to the broader healthcare system. Regarding the chronic disease management programme, the State has invested in GP services for the benefit of people of a particular age who may face chronic diseases. This is showing dividends in terms of patient care and in terms of the number of exacerbations and presentations to acute hospitals. People are living better with chronic diseases because of our investment in GPs and because they can access it more easily.
I am concerned that there is not the same availability of out-of-hours GPs across the regions. That is putting additional pressures on emergency departments and local injury units, particularly at a time of rising population. I am particularly conscious of that in the mid-west and south west, but it is a national profile. That is something I need to make sure is included in any new contract. I have a number of other reflections about maximising the use of GP services so that we are getting the best in the community and reducing hospital presentations.
It is important to say that our development of pharmacy contracts enables better access to GPs. Let me say loudly again that you do not need to go to your GP for eight conditions, including a simple eye infection, thrush or a urinary tract infection. You can go directly to your pharmacy and pay €30 for a consultation with a pharmacist, a diagnosis and a prescription. You need never go to two different places when you have such conditions. Who does that matter for? Everybody. It matters because it creates more space in GP practices for somebody who needs a prescription for a urinary tract infection. For an older lady, such an infection is a really serious thing that can get much worse and result in hospitalisation. Because we have changed the pathway, people can get quicker diagnosis and an appropriate prescription to clear up a basic but important and potentially risky infection. In all those ways, we have tried to expand access to appropriate medical care.